Ainos, Inc. (AIMD)

Market Cap	10.62M
Revenue (ttm)	106,207
Net Income (ttm)	-14.83M
Shares Out	4.15M
EPS (ttm)	-6.17
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,121
Open	2.560
Previous Close	2.600
Day's Range	2.500 - 2.600
52-Week Range	2.000 - 5.000
Beta	2.15
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 8, 2025

About AIMD

Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data. The company is also giving AI for robotics, smart factories, senior care, and women’s health. In addition, it develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal health. The company was formerly known as Amarillo ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 44
• Stock Exchange: NASDAQ
• Ticker Symbol: AIMD
• Website: https://www.ainos.com

Financial Performance

In 2024, Ainos's revenue was $20,729, a decrease of -83.02% compared to the previous year's $122,112. Losses were -$14.86 million, 7.93% more than in 2023.